SenesTech announces warrant exercise for $6.3M in gross proceeds
Warrant Exercise Announcement: SenesTech has entered into agreements for the immediate exercise of warrants to purchase 1,458,872 shares of common stock at $4.15 per share, with the transaction expected to close around August 5.
New Short-Term Warrants Issued: In exchange for the existing warrants, SenesTech will issue new short-term warrants for 2,188,308 shares at an exercise price of $5.25, potentially raising approximately $11.5 million if fully exercised.
Trade with 70% Backtested Accuracy
Analyst Views on SNES
No data
About SNES
About the author
SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve® Rat Birth Control
Introduction of Evolve® Rat Birth Control: SenesTech, Inc. has partnered with Sarah Mann and the Belize Raptor Center to introduce Evolve® Rat Birth Control in Belize, aiming to manage rodent populations humanely and sustainably amidst rising concerns over toxic rodenticides.
Ecological Impact and Education Campaign: The initiative addresses the ecological threats posed by unregulated rodenticides, launching a grassroots education campaign to inform the public about the dangers of these poisons and promote fertility control as a safer alternative.
SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA
Financial Performance: SenesTech reported a 43% increase in revenues for Q3 2025, reaching $690,000, with Evolve® Rodent Birth Control™ products driving a 77% year-over-year growth, now accounting for 85% of total revenue.
Operational Highlights: The company saw significant growth in various channels, including a 139% increase in municipal revenue and a 254% rise in retail revenue, supported by expanded partnerships and e-commerce sales.
Profitability Progress: Despite a net loss of $1.3 million, the adjusted EBITDA loss improved to $1.2 million, indicating progress towards profitability, bolstered by a strong cash balance of $10.2 million.
Strategic Outlook: CEO Joel Fruendt emphasized the company's commitment to pursuing profitable growth and expanding its innovative pest control product line, aiming for breakeven and long-term market potential.
